{"entity":{"type":"insider","cik":"0001776196","url":"/insider/0001776196","json_url":"/insider/0001776196.json","name":"Lynch Brian Joseph","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":32,"n_filings":4,"first":"2022-12-28","last":"2023-12-06","span_basis":"filed_date"},"name_variants":[{"name":"Lynch Brian Joseph","source":"filing","n_filings":4,"first_seen":"2022-12-28","last_seen":"2023-12-06"}],"transactions":[{"id":8465593,"accession":"0000950170-23-068575","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0000950170-23-068575","line_url":"/filing/0000950170-23-068575#line-6","is_derivative":false,"issuer_cik":"0001157601","issuer_name":"MADRIGAL PHARMACEUTICALS, INC.","issuer_ticker":"MDGL","issuer_name_source":null,"issuer_url":"/issuer/0001157601","owner_cik":"0001776196","owner_name":"Lynch Brian Joseph","owner_display_name":"Lynch Brian Joseph","owner_url":"/insider/0001776196","role":"Officer (SVP and General Counsel)","role_mark":"O","role_mark_label":"Officer (SVP and General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP and General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1000.0,"shares_display":"1,000","price_per_share":227.33,"price_display":"227.33","price_state":"stated","total_value":227330.0,"total_display":"227,330.00","total_whole":"227,330","shares_owned_after":15001.0,"shares_owned_after_display":"15,001","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-12-05","filed_date":"2023-12-06","scope":"insider"},{"id":8465587,"accession":"0000950170-23-068575","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000950170-23-068575","line_url":"/filing/0000950170-23-068575","is_derivative":false,"issuer_cik":"0001157601","issuer_name":"MADRIGAL PHARMACEUTICALS, INC.","issuer_ticker":"MDGL","issuer_name_source":null,"issuer_url":"/issuer/0001157601","owner_cik":"0001776196","owner_name":"Lynch Brian Joseph","owner_display_name":"Lynch Brian Joseph","owner_url":"/insider/0001776196","role":"Officer (SVP and General Counsel)","role_mark":"O","role_mark_label":"Officer (SVP and General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP and General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1800.0,"shares_display":"1,800","price_per_share":218.86888888888888,"price_display":"218.87","price_state":"stated","total_value":393964.0,"total_display":"393,964.00","total_whole":"393,964","shares_owned_after":15001.0,"shares_owned_after_display":"15,001","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-12-04","filed_date":"2023-12-06","scope":"insider","n_lines":2},{"id":8353771,"accession":"0000950170-23-067360","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0000950170-23-067360","line_url":"/filing/0000950170-23-067360","is_derivative":false,"issuer_cik":"0001157601","issuer_name":"MADRIGAL PHARMACEUTICALS, INC.","issuer_ticker":"MDGL","issuer_name_source":null,"issuer_url":"/issuer/0001157601","owner_cik":"0001776196","owner_name":"Lynch Brian Joseph","owner_display_name":"Lynch Brian Joseph","owner_url":"/insider/0001776196","role":"Officer (SVP and General Counsel)","role_mark":"O","role_mark_label":"Officer (SVP and General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP and General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":204.57666666666665,"price_display":"204.58","price_state":"stated","total_value":613730.0,"total_display":"613,730.00","total_whole":"613,730","shares_owned_after":15001.0,"shares_owned_after_display":"15,001","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-11-30","filed_date":"2023-12-01","scope":"insider","n_lines":3},{"id":8353752,"accession":"0000950170-23-067360","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000950170-23-067360","line_url":"/filing/0000950170-23-067360","is_derivative":false,"issuer_cik":"0001157601","issuer_name":"MADRIGAL PHARMACEUTICALS, INC.","issuer_ticker":"MDGL","issuer_name_source":null,"issuer_url":"/issuer/0001157601","owner_cik":"0001776196","owner_name":"Lynch Brian Joseph","owner_display_name":"Lynch Brian Joseph","owner_url":"/insider/0001776196","role":"Officer (SVP and General Counsel)","role_mark":"O","role_mark_label":"Officer (SVP and General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP and General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4000.0,"shares_display":"4,000","price_per_share":199.1875,"price_display":"199.19","price_state":"stated","total_value":796750.0,"total_display":"796,750.00","total_whole":"796,750","shares_owned_after":15001.0,"shares_owned_after_display":"15,001","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-11-29","filed_date":"2023-12-01","scope":"insider","n_lines":2},{"id":8100910,"accession":"0000899243-23-001137","txn_seq":11,"anchor":"line-11","filing_url":"/filing/0000899243-23-001137","line_url":"/filing/0000899243-23-001137","is_derivative":false,"issuer_cik":"0001157601","issuer_name":"MADRIGAL PHARMACEUTICALS, INC.","issuer_ticker":"MDGL","issuer_name_source":null,"issuer_url":"/issuer/0001157601","owner_cik":"0001776196","owner_name":"Lynch Brian Joseph","owner_display_name":"Lynch Brian Joseph","owner_url":"/insider/0001776196","role":"Officer (SVP and General Counsel)","role_mark":"O","role_mark_label":"Officer (SVP and General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP and General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13000.0,"shares_display":"13,000","price_per_share":282.9212769230769,"price_display":"282.92","price_state":"stated","total_value":3677976.6,"total_display":"3,677,976.60","total_whole":"3,677,977","shares_owned_after":7544.0,"shares_owned_after_display":"7,544","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-03","filed_date":"2023-01-06","scope":"insider","n_lines":10},{"id":6691848,"accession":"0000899243-22-039464","txn_seq":15,"anchor":"line-15","filing_url":"/filing/0000899243-22-039464","line_url":"/filing/0000899243-22-039464","is_derivative":false,"issuer_cik":"0001157601","issuer_name":"MADRIGAL PHARMACEUTICALS, INC.","issuer_ticker":"MDGL","issuer_name_source":null,"issuer_url":"/issuer/0001157601","owner_cik":"0001776196","owner_name":"Lynch Brian Joseph","owner_display_name":"Lynch Brian Joseph","owner_url":"/insider/0001776196","role":"Officer (SVP and General Counsel)","role_mark":"O","role_mark_label":"Officer (SVP and General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP and General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7000.0,"shares_display":"7,000","price_per_share":274.17581285714283,"price_display":"274.18","price_state":"stated","total_value":1919230.69,"total_display":"1,919,230.69","total_whole":"1,919,231","shares_owned_after":3200.0,"shares_owned_after_display":"3,200","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-12-23","filed_date":"2022-12-28","scope":"insider","n_lines":14}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":32,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":32,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":32},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001157601","name":"MADRIGAL PHARMACEUTICALS, INC.","url":"/issuer/0001157601","role":"Officer (SVP and General Counsel)","n_filings":4,"first_seen":"2022-12-28","last_seen":"2023-12-06"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001776196","retrieved_at":"2026-08-22T21:02:04+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}